Global Plasma Therapy Market Research Report Insights, Opportunity Analysis, Market Shares and Forecast, 2017 - 2023

  • ID: 4447144
  • Report
  • Region: Global
  • 190 Pages
  • Occams Business Research and Consulting
1 of 4
The Global Plasma Therapy Market is Expected to Rise at a CAGR of 14.5% During 2016-2023.

FEATURED COMPANIES

  • Arthrex (U.S.)
  • Biotest (Germany)
  • CSL Ltd. (U.S.)
  • Depuy Synthes Inc. (U.S.)
  • Kedrion S.P.A. (Italy)
  • LFB Sa (France)
  • MORE

The global plasma therapy market is expected to rise at a CAGR of 14.5% during the forecast period 2016-2023. The key factors driving the market growth are rising incidences of sports injuries, increase in the number of androgenic alopecia patients worldwide, growing use of platelet-rich plasma in various therapeutic areas and prevalence of arthritis.

Geographically, North America is the leading market for global plasma therapy in terms of market revenue share. The key factors driving the market growth in North America is the rising number of incidences of sports injuries and orthopaedic diseases.  Moreover, the availability of advanced healthcare facilities along with improved diagnostics has driven the market growth in North America. However, Asia Pacific is expected to emerge as the fastest growing market region during forecast period. This is due to the increasing geriatric population, which has further led to surging demand for cosmetic surgeries. As per the HelpAge organization, more than 75% of the Indian population are aged between 80-84 years. Moreover, 20.8% of the population in India are of age between 85-90 years and approximately 3.8% of the population in India is found to be above the age of 90.

The global plasma therapy market is influenced by the presence of leading companies, such as Arthrex, Biolife Plasma Services, Cambryn Biologics LLC, Depuy Synthes Inc., Harvest Technologies Corp. Product launch, joint venture, merger and acquisition are some of the crucial strategies adopted by the key market players to gain competitive advantage. 

Global plasma therapy market report covers segmentation analysis of type, source, applications and end users. On the basis of types of plasma, the market is divided into pure platelet rich plasma, leukocyte-rich platelet rich plasma, pure platelet-rich fibrin and leukocyte-rich fibrin. The pure platelet rich plasma is dominating type segment owing to its high success rate and effective antimicrobial effects. On the basis of source type, market is divided into autologous and allogenic. Autologous is the dominating source segment due to the increasing prevalence of orthopaedic disorders such as tendinitis and arthritis, thereby leading to advanced plasma therapy treatment option. Whereas, plasma therapy is deployed in various applications, such as orthopedic, dermatology, cardiac muscle injury, dental, nerve injury etc. The dermatology is the dominating application segment due to the increasing demand for cosmetic surgeries and procedures. The end users of plasma therapy include hospitals & clinics and research institutes. The hospitals and clinics is the leading end user segment due to the increasing healthcare expenditure.

READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Arthrex (U.S.)
  • Biotest (Germany)
  • CSL Ltd. (U.S.)
  • Depuy Synthes Inc. (U.S.)
  • Kedrion S.P.A. (Italy)
  • LFB Sa (France)
  • MORE

1. Introduction
1.1. Executive Summary
1.2. Estimation Methodology
 
2. Market Overview
2.1. Global Plasma Therapy Market : Evolution & Transition
2.2. Market Definition & Scope
2.3. Industry Structure
2.4. Regulatory Framework
2.5. Total Market Analysis
2.5.1. Top 5 Findings
2.5.2. Top 5 Opportunity Markets
2.5.3. Top 5 Companies
2.5.4. Top 3 Competitive Strategies
2.6. Estimation Analysis
2.7. Strategic Analysis
2.7.1. Investment Vs. Adoption Model
2.7.2. 360-Degree Industry Analysis
2.7.3. Porters 5 Force Model
2.7.4. See-Saw Analysis
2.7.5. Consumer Analysis And Key Buying Criteria
2.8. Competitive Analysis
2.8.1. Key Strategies & Analysis
2.8.2. Market Share Analysis & Top Company Analysis
2.9. Strategic Recommendations & Key Conclusions
2.9.1. Investment Opportunities By Regions
2.9.2. Opportunities in Emerging Applications
2.9.3. Investment Opportunity in Fastest Growing Segment
 
3. Market Determinants
3.1. Market Drivers
3.1.1. Increasing Incidences of Sports Related Injuries
3.1.2. Rising Number of Androgenic Alopecia Patients Worldwide
3.1.3. Rapid Deployment of Platelet-Rich Plasma in Various Therapeutic Areas
3.1.4. Increasing Prevalence of Arthritis
3.2. Market Restraints
3.2.1. Insufficient Reimbursement Policies
3.2.2. Fluctuating Prices of Plasma Therapy
3.3. Market Opportunities
3.3.1. Increasing Prevalence of Orthopedic Disorders
3.4. Market Challenges
3.4.1. Limited Usage of Platelet Rich Plasma for Diabetic And Kidney Patients
3.4.2. Developments in Regenerative Medicine
 
4. Market Segmentation
4.1. Global Plasma Therapy Market By Type
4.1.1. Market Definition And Scope
4.1.2. Decision Support Database & Estimation Methodology
4.1.3. Comparative Analysis Across Market Segments
4.1.4. Opportunity Matrix
4.1.5. Market Segmentation
4.1.5.1. Global Pure Platelet Rich Plasma Market
4.1.5.1.1. Adoption Scenario & Market Determinants
4.1.5.1.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.1.5.1.3. Key Players & Key Products
4.1.5.1.4. Key Conclusions
4.1.5.2. Global Leukocyte-Rich Platelet Rich Plasma Market
4.1.5.2.1. Adoption Scenario & Market Determinants
4.1.5.2.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.1.5.2.3. Key Players & Key Products
4.1.5.2.4. Key Conclusions
4.1.5.3. Global Pure Platelet-Rich Fibrin Market
4.1.5.3.1. Adoption Scenario & Market Determinants
4.1.5.3.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.1.5.3.3. Key Players & Key Products
4.1.5.3.4. Key Conclusions
4.1.5.4. Global Leukocyte-Rich Fibrin Market
4.1.5.4.1. Adoption Scenario & Market Determinants
4.1.5.4.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.1.5.4.3. Key Players & Key Products
4.1.5.4.4. Key Conclusions
4.2. Global Plasma Therapy Market By Source
4.2.1. Market Definition And Scope
4.2.2. Decision Support Database & Estimation Methodology
4.2.3. Comparative Analysis Across Market Segments
4.2.4. Opportunity Matrix
4.2.5. Market Segmentation
4.2.5.1. Global Autologous Market
4.2.5.1.1. Adoption Scenario & Market Determinants
4.2.5.1.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.2.5.1.3. Key Players & Key Products
4.2.5.1.4. Key Conclusions
4.2.5.2. Global Allogenic Market
4.2.5.2.1. Adoption Scenario & Market Determinants
4.2.5.2.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.2.5.2.3. Key Players & Key Products
4.2.5.2.4. Key Conclusions
4.3. Global Plasma Therapy Market By Application
4.3.1. Market Definition And Scope
4.3.2. Decision Support Database & Estimation Methodology
4.3.3. Comparative Analysis Across Market Segments
4.3.4. Opportunity Matrix
4.3.5. Market Segmentation
4.3.5.1. Global Orthopedic Market
4.3.5.1.1. Adoption Scenario & Market Determinants
4.3.5.1.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.3.5.1.3. Key Players & Key Products
4.3.5.1.4. Key Conclusions
4.3.5.2. Global Dermatology Market
4.3.5.2.1. Adoption Scenario & Market Determinants
4.3.5.2.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.3.5.2.3. Key Players & Key Products
4.3.5.2.4. Key Conclusions
4.3.5.3. Global Cardiac Muscle Injury Market
4.3.5.3.1. Adoption Scenario & Market Determinants
4.3.5.3.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.3.5.3.3. Key Players & Key Products
4.3.5.3.4. Key Conclusions
4.3.5.4. Global Dental Market
4.3.5.4.1. Adoption Scenario & Market Determinants
4.3.5.4.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.3.5.4.3. Key Players & Key Products
4.3.5.4.4. Key Conclusions
4.3.5.5. Global Nerve Injury Market
4.3.5.5.1. Adoption Scenario & Market Determinants
4.3.5.5.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.3.5.5.3. Key Players & Key Products
4.3.5.5.4. Key Conclusions
4.3.5.6. Global Other Applications Market
4.3.5.6.1. Adoption Scenario & Market Determinants
4.3.5.6.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.3.5.6.3. Key Players & Key Products
4.3.5.6.4. Key Conclusions
4.4. Global Plasma Therapy Market By End Users
4.4.1. Market Definition And Scope
4.4.2. Decision Support Database & Estimation Methodology
4.4.3. Comparative Analysis Across Market Segments
4.4.4. Opportunity Matrix
4.4.5. Market Segmentation
4.4.5.1. Global Hospitals & Clinics Market
4.4.5.1.1. Adoption Scenario & Market Determinants
4.4.5.1.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.4.5.1.3. Key Players & Key Products
4.4.5.1.4. Key Conclusions
4.4.5.2. Global Research Institutes Market
4.4.5.2.1. Adoption Scenario & Market Determinants
4.4.5.2.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.4.5.2.3. Key Players & Key Products
4.4.5.2.4. Key Conclusions
 
5. Competitive Landscape
5.1. Key Strategies
5.1.1. List of Mergers And Acquisition
5.1.2. List of Joint Ventures
5.1.3. List of Product Launches
5.1.4. List of Partnerships
 
6. Geographic Analysis
6.1. Decision Support Database & Estimation Methodology
6.2. Comparative Analysis Across Market Segments
6.3. Opportunity Matrix
6.4. Global Plasma Therapy Market By Region 2014-2023 ($ Million)
6.4.1. North America
6.4.1.1. Industry Analysis 2014-2023 ($ Million)
6.4.1.2. Top Country Analysis
6.4.1.2.1. U.S.
6.4.1.2.1.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.1.2.1.2. Key Players & Key Products
6.4.1.2.1.3. Key Conclusions
6.4.1.2.2. Canada
6.4.1.2.2.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.1.2.2.2. Key Players & Key Products
6.4.1.2.2.3. Key Conclusions
6.4.2. Europe
6.4.2.1. Industry Analysis 2014-2023 ($ Million)
6.4.2.2. Top Country Analysis
6.4.2.2.1. Uk
6.4.2.2.1.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.2.2.1.2. Key Players & Key Products
6.4.2.2.1.3. Key Conclusions
6.4.2.2.2. France
6.4.2.2.2.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.2.2.2.2. Key Players & Key Products
6.4.2.2.2.3. Key Conclusions
6.4.2.2.3. Germany
6.4.2.2.3.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.2.2.3.2. Key Players & Key Products
6.4.2.2.3.3. Key Conclusions
6.4.2.2.4. Spain
6.4.2.2.4.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.2.2.4.2. Key Players & Key Products
6.4.2.2.4.3. Key Conclusions
6.4.2.2.5. Rest of Europe
6.4.2.2.5.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.2.2.5.2. Key Players & Key Products
6.4.2.2.5.3. Key Conclusions
6.4.3. Asia Pacific
6.4.3.1. Industry Analysis 2014-2023 ($ Million)
6.4.3.2. Top Country Analysis
6.4.3.2.1. China
6.4.3.2.1.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.3.2.1.2. Key Players & Key Products
6.4.3.2.1.3. Key Conclusions
6.4.3.2.2. India
6.4.3.2.2.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.3.2.2.2. Key Players & Key Products
6.4.3.2.2.3. Key Conclusions
6.4.3.2.3. Japan
6.4.3.2.3.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.3.2.3.2. Key Players & Key Products
6.4.3.2.3.3. Key Conclusions
6.4.3.2.4. Australia
6.4.3.2.4.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.3.2.4.2. Key Players & Key Products
6.4.3.2.4.3. Key Conclusions
6.4.3.2.5. Rest of Asia Pacific
6.4.3.2.5.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.3.2.5.2. Key Players & Key Products
6.4.3.2.5.3. Key Conclusions
6.4.4. Row
6.4.4.1. Industry Analysis 2014-2023 ($ Million)
6.4.4.2. Top Country Analysis
6.4.4.2.1. Latin America
6.4.4.2.1.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.4.2.1.2. Key Players & Key Products
6.4.4.2.1.3. Key Conclusions
6.4.4.2.2. Middle East & Africa
6.4.4.2.2.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.4.2.2.2. Key Players & Key Products
6.4.4.2.2.3. Key Conclusions
 
7. Company Profiles
7.1. Arthrex (U.S.)
7.1.1. Overview
7.1.2. Product Portfolio
7.1.3. Strategic Initiatives
7.1.4. Scot Analysis
7.1.5. Strategic Analysis
7.2. Biolife Plasma Services (U.S.)
7.2.1. Overview
7.2.2. Product Portfolio
7.2.3. Strategic Initiatives
7.2.4. Scot Analysis
7.2.5. Strategic Analysis
7.3. Bio Product Laboratory Ltd. (U.K.)
7.3.1. Overview
7.3.2. Product Portfolio
7.3.3. Strategic Initiatives
7.3.4. Scot Analysis
7.3.5. Strategic Analysis
7.4. Biotest (Germany)
7.4.1. Overview
7.4.2. Product Portfolio
7.4.3. Strategic Initiatives
7.4.4. Scot Analysis
7.4.5. Strategic Analysis
7.5. Cambryn Biologics Llc (U.S.)
7.5.1. Overview
7.5.2. Product Portfolio
7.5.3. Strategic Initiatives
7.5.4. Scot Analysis
7.5.5. Strategic Analysis
7.6. China Biologic Products Inc. (China)
7.6.1. Overview
7.6.2. Product Portfolio
7.6.3. Strategic Initiatives
7.6.4. Scot Analysis
7.6.5. Strategic Analysis
7.7. Csl Ltd. (U.S.)
7.7.1. Overview
7.7.2. Product Portfolio
7.7.3. Strategic Initiatives
7.7.4. Scot Analysis
7.7.5. Strategic Analysis
7.8. Depuy Synthes Inc. (U.S.)
7.8.1. Overview
7.8.2. Product Portfolio
7.8.3. Strategic Initiatives
7.8.4. Scot Analysis
7.8.5. Strategic Analysis
7.9. Grifols International S.A. (Australia)
7.9.1. Overview
7.9.2. Product Portfolio
7.9.3. Strategic Initiatives
7.9.4. Scot Analysis
7.9.5. Strategic Analysis
7.10. Harvest Technologies Corp (U.S.)
7.10.1. Overview
7.10.2. Product Portfolio
7.10.3. Strategic Initiatives
7.10.4. Scot Analysis
7.10.5. Strategic Analysis
7.11. Kedrion S.P.A. (Italy)
7.11.1. Overview
7.11.2. Product Portfolio
7.11.3. Strategic Initiatives
7.11.4. Scot Analysis
7.11.5. Strategic Analysis
7.12. Lfb Sa (France)
7.12.1. Overview
7.12.2. Product Portfolio
7.12.3. Strategic Initiatives
7.12.4. Scot Analysis
7.12.5. Strategic Analysis
7.13. Octapharma (Switzerland)
7.13.1. Overview
7.13.2. Product Portfolio
7.13.3. Strategic Initiatives
7.13.4. Scot Analysis
7.13.5. Strategic Analysis
7.14. Regen Lab Sa (Switzerland)
7.14.1. Overview
7.14.2. Product Portfolio
7.14.3. Strategic Initiatives
7.14.4. Scot Analysis
7.14.5. Strategic Analysis
7.15. Stryker Corporation (U.S.)
7.15.1. Overview
7.15.2. Product Portfolio
7.15.3. Strategic Initiatives
7.15.4. Scot Analysis
7.15.5. Strategic Analysis
 
List of Tables
1. Global Plasma Therapy Market By Type 2014-2023 ($ Million)
2. Global Pure Platelet Rich Plasma Market By Geography 2014-2023 ($ Million)
3. Global Leukocyte-Rich Platelet Rich Plasma Market By Geography 2014-2023 ($ Million)
4. Global Pure Platelet-Rich Fibrin Market By Geography 2014-2023 ($ Million)
5. Global Leukocyte-Rich Fibrin Market By Geography 2014-2023 ($ Million)
6. Global Plasma Therapy Market By Source 2014-2023 ($ Million)
7. Global Autologous Market By Geography 2014-2023 ($ Million)
8. Global Allogenic Market By Geography 2014-2023 ($ Million)
9. Global Plasma Therapy Market By Applications 2014-2023 ($ Million)
10. Global Orthopedic Market By Geography 2014-2023 ($ Million)
11. Global Dermatology Market By Geography 2014-2023 ($ Million)
12. Global Cardiac Muscle Injury Market By Geography 2014-2023 ($ Million)
13. Global Dental Market By Geography 2014-2023 ($ Million)
14. Global Nerve Injury Market By Geography 2014-2023 ($ Million)
15. Global Other Applications Market By Geography 2014-2023 ($ Million)
16. Global Plasma Therapy Market By End Users 2014-2023 ($ Million)
17. Global Hospitals & Clinics Market By Geography 2014-2023 ($ Million)
18. Global Research Institutes Market By Geography 2014-2023 ($ Million)
19. North America Plasma Therapy Market 2014-2023 ($ Million)
20. Europe Plasma Therapy Market 2014-2023 ($ Million)
21. Asia Pacific Plasma Therapy Market 2014-2023 ($ Million)
22. Rest of the World Plasma Therapy Market 2014-2023 ($ Million)
 
List of Figures
1. Global Pure Platelet Rich Plasma Market 2014-2023 ($ Million)
2. Global Leukocyte-Rich Platelet Rich Plasma Market 2014-2023 ($ Million)
3. Global Pure Platelet-Rich Fibrin Market 2014-2023 ($ Million)
4. Global Leukocyte-Rich Fibrin Market 2014-2023 ($ Million)
5. Global Autologous Market 2014-2023 ($ Million)
6. Global Allogenic Market 2014-2023 ($ Million)
7. Global Orthopedic Market 2014-2023 ($ Million)
8. Global Dermatology Market 2014-2023 ($ Million)
9. Global Cardiac Muscle Injury Market 2014-2023 ($ Million)
10. Global Dental Market 2014-2023 ($ Million)
11. Global Nerve Injury Market 2014-2023 ($ Million)
12. Global Other Applications Market 2014-2023 ($ Million)
13. Global Hospitals & Clinics Market 2014-2023 ($ Million)
14. Global Research Institutes Market 2014-2023 ($ Million)
15. United States (U.S.) Plasma Therapy Market 2014-2023 ($ Million)
16. Canada Plasma Therapy Market 2014-2023 ($ Million)
17. United Kingdom (Uk) Plasma Therapy Market 2014-2023 ($ Million)
18. France Plasma Therapy Market 2014-2023 ($ Million)
19. Germany Plasma Therapy Market 2014-2023 ($ Million)
20. Spain Plasma Therapy Market 2014-2023 ($ Million)
21. Roe Plasma Therapy Market 2014-2023 ($ Million)
22. India Plasma Therapy Market 2014-2023 ($ Million)
23. China Plasma Therapy Market 2014-2023 ($ Million)
24. Japan Plasma Therapy Market 2014-2023 ($ Million)
25. Australia Plasma Therapy Market 2014-2023 ($ Million)
26. Roapac Plasma Therapy Market 2014-2023 ($ Million)
27. Latin America Plasma Therapy Market 2014-2023 ($ Million)
28. Mena Plasma Therapy Market 2014-2023 ($ Million)

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Arthrex (U.S.)
  • Bio Product Laboratory Ltd. (U.K.)
  • Biolife Plasma Services (U.S.)
  • Biotest (Germany)
  • Cambryn Biologics Llc (U.S.)
  • China Biologic Products Inc. (China)
  • CSL Ltd. (U.S.)
  • Depuy Synthes Inc. (U.S.)
  • Grifols International S.A. (Australia)
  • Harvest Technologies Corp (U.S.)
  • Kedrion S.P.A. (Italy)
  • LFB Sa (France)
  • Octapharma (Switzerland)
  • Regen Lab Sa (Switzerland)
  • Stryker Corporation (U.S.)
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll